Comparing ER+ and TN breast tumor cell lines, our data now show that overall Siglec‐7 ligand and Siglec‐9 ligand expression is higher on TN cell lines relative to ER+ cell lines. The gene discussed is SIGLEC9; the disease is breast neoplasm.